Discover Expert
Implementation Tips for Using Clinical Trials Data
Learn More!
Online
Log in
Explore
Drug Knowledgebase
Start here! Dig into essential drug information
Advanced Exploration
Categories & ATC Classifications
Pathways
Drug Reactions
Drug Classification
Drug Targets
Advanced Search
Target Sequence
Spectra Search
Pharmaco-omics
Chemical Structure
Data Library
Academic Downloads
Interaction Checker
Get More
Navigate to
DrugBank.com
to check out our commercial products, use cases and more!
DrugBank For Clinical Software
Clinical API
Clinical intelligence tool for your software
Features
Drug Search
Customizable drug search options
Drug-Drug Interaction Checker
Search for drug interactions with our API
Drug Allergy
Get drug allergy and cross sensitivities info
US Drug Labels
Integrate drug manufacturer information
Log in
Drugs
Targets
Pathways
Indications
Drugs
Drugs
Targets
Pathways
Indications
Log in or create an account for full access to this data.
Create Account
Log in
Refractory Osteosarcoma
Drug Trials
Drug
Drug Name
Drug Description
Drug
Drug Name
Target
Type
Drug
Drug Name
Phase
Status
Count
DB08875
Cabozantinib
1
Completed
1
DB00531
Cyclophosphamide
1
Completed
1
DB00531
Cyclophosphamide
1
Suspended
1
DB00099
Filgrastim
1
Completed
1
DB01073
Fludarabine
1
Suspended
1
DB00019
Pegfilgrastim
1
Completed
1
DB01030
Topotecan
1
Completed
1
DB01248
Docetaxel
1 / 2
Active Not Recruiting
1
DB00441
Gemcitabine
1 / 2
Active Not Recruiting
1
DB01611
Hydroxychloroquine
1 / 2
Active Not Recruiting
1
DB06186
Ipilimumab
1 / 2
Completed
1
DB00762
Irinotecan
1 / 2
Recruiting
1
DB09035
Nivolumab
1 / 2
Completed
1
DB15155
Pepinemab
1 / 2
Active Not Recruiting
1
DB11760
Talazoparib
1 / 2
Recruiting
1
DB17109
Tegavivint
1 / 2
Recruiting
1
DB00853
Temozolomide
1 / 2
Recruiting
1
DB00041
Aldesleukin
2
Active Not Recruiting
1
DB11595
Atezolizumab
2
Recruiting
1
DB08875
Cabozantinib
2
Active Not Recruiting
1
DB08875
Cabozantinib
2
Recruiting
1
DB00531
Cyclophosphamide
2
Active Not Recruiting
1
DB06643
Denosumab
2
Completed
1
DB11714
Durvalumab
2
Recruiting
1
DB14860
Ensartinib
2
Recruiting
2
DB12147
Erdafitinib
2
Recruiting
1
DB01073
Fludarabine
2
Active Not Recruiting
1
DB15127
Hydrogen
2
Recruiting
1
DB06186
Ipilimumab
2
Active Not Recruiting
1
DB14568
Ivosidenib
2
Active Not Recruiting
1
DB12167
LY-3023414
2
Recruiting
1
DB14723
Larotrectinib
2
Active Not Recruiting
1
DB14723
Larotrectinib
2
Recruiting
1
DB17107
Lifileucel
2
Active Not Recruiting
1
DB14123
Menthol
2
Recruiting
1
DB09035
Nivolumab
2
Active Not Recruiting
1
DB09074
Olaparib
2
Active Not Recruiting
1
DB09074
Olaparib
2
Recruiting
1
DB15088
Oleclumab
2
Recruiting
1
DB09073
Palbociclib
2
Active Not Recruiting
1
DB09073
Palbociclib
2
Recruiting
1
DB15685
Selpercatinib
2
Active Not Recruiting
1
DB15685
Selpercatinib
2
Recruiting
1
DB11689
Selumetinib
2
Recruiting
1
DB14546
Sulfate ion
2
Active Not Recruiting
1
DB14546
Sulfate ion
2
Recruiting
1
DB12887
Tazemetostat
2
Active Not Recruiting
1
DB12887
Tazemetostat
2
Recruiting
1
DB04960
Tipifarnib
2
Active Not Recruiting
1
DB04960
Tipifarnib
2
Recruiting
1
DB13930
Ulixertinib
2
Active Not Recruiting
1
DB13930
Ulixertinib
2
Recruiting
1
DB08881
Vemurafenib
2
Recruiting
1
DB13104
X-396
2
Recruiting
2